Compare Vemlidy vs. Pegasys
Head-to-head comparisons of medication uses, side effects, ratings, and more.
Treats hepatitis B virus (HBV) infections.
Vemlidy (tenofovir alafenamide) decreases liver damage from hepatitis B virus (HBV) and has minimal side effects, but doesn't cure the infection.
No information currently available
Upsides
- Vemlidy (tenofovir alafenamide) is a first-choice medicine to treat hepatitis B.
- Conveniently taken once daily.
- Compared to Truvada and Viread (tenofovir disoproxil fumarate), Vemlidy (tenofovir alafenamide) is safer for your kidneys and bones.
No information currently available
Downsides
- Might not be the best choice for people with severe kidney damage.
- There's not enough evidence to show that Vemlidy (tenofovir alafenamide) can be used safely in children ages 18 or younger.
No information currently available
Used for
- Hepatitis B treatment
- Active type B viral hepatitis
- Chronic Hepatitis C
- Chronic
- In patients with compensated liver disease - HIV infection Hepatitis C
- Chronic
- Interferon alfa-naive
- With compensated liver disease
- Hepatitis C
- Chronic
- Interferon alfa/ribavirin nonresponders
Dosage forms
- Pill
- Injection
Price
Lowest price
$1370.83
Find instant savings near youLowest price
$4063.56
Find instant savings near youWant to save even more money?
Sign up now for a 30-day trial and save up to 95% at CVS, Kroger, Albertsons, and other pharmacies.
Learn more
Reviews
Not enough review data.Leave a review
Not enough review data.Leave a review
Side effects
6possible side effects
- Headache9%
- Stomach pain7%
- Tiredness6%
- Cough6%
- Nausea5%
- Back pain5%
The Pegasys (Peginterferon Alfa-2A) FDA package insert doesn’t have numbers about how common side effects are.
Risks and risk factors
- Worsening of hepatitis B infection
- Stopping Vemlidy (tenofovir alafenamide)
- Hepatitis B and HIV co-infection
- HIV infection
- Kidney damage
- Poor kidney function
- Taking other medicines that can damage the kidneys
- Buildup of acid in the blood and swollen, fatty liver
- Lowered bone mineral density
- Long-term use of Vemlidy (tenofovir alafenamide)
- Use of other medications that result in loss of electrolytes or minerals
No information currently available